Medline (MDLN) EBITDA (2025 - 2026)
Medline's (MDLN) quarterly EBITDA came in at $395.0 million in Q2 2026, down 38.47% year-over-year from $642.0 million in Q2 2025, and down 6.4% quarter-over-quarter from $422.0 million in Q1 2026.
Powered by 
Analysis
Medline (MDLN) EBITDA (2025 - 2026) Analysis & Trends
Medline (MDLN) has reported EBITDA for 2 consecutive years, with $395.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA fell 38.47% year-over-year to $395.0 million in Q2 2026; TTM through Jun 2026 was $2.0 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $2.2 billion, up 3.08% from the prior year.
- EBITDA was $395.0 million for Q2 2026 at Medline, down from $422.0 million in the prior quarter.
- Over five years, EBITDA peaked at $642.0 million in Q2 2025 and troughed at $395.0 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 663.00 Mn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 395.00 Mn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 179.10 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 217.00 Mn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 45.39 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 6.83 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | -1.06 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | -5.15 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | -166,850.00 |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 395.00 Mn |
| Mar 28, 2026 | 422.00 Mn |
| Jun 28, 2025 | 642.00 Mn |
| Mar 29, 2025 | 571.00 Mn |